000 01258 a2200301 4500
005 20250517065807.0
264 0 _c20160510
008 201605s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2015.64.2546
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOffer, Steven M
245 0 0 _aIs It Finally Time for a Personalized Medicine Approach for Fluorouracil-Based Therapies?
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJan 2016
300 _a205-7 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aDihydrouracil Dehydrogenase (NADP)
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenotyping Techniques
_xmethods
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPrecision Medicine
_xmethods
650 0 4 _aPyrimidines
_xadministration & dosage
700 1 _aDiasio, Robert B
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 34
_gno. 3
_gp. 205-7
856 4 0 _uhttps://doi.org/10.1200/JCO.2015.64.2546
_zAvailable from publisher's website
999 _c25520844
_d25520844